Abstract
This paper presents a method for measuring the heteroplasmy level of mitochondrial DNA mutations, which is based on real-time PCR using TaqMan fluorescent probes. The method makes it possible to detect the heteroplasmy level of mtDNA mutations and has high accuracy and resolution. It shows significant differences between the parameters of heteroplasmy of patients belonging to different groups by the degree of disease. Application of this method, in particular, to determine the predisposition to atherosclerosis, makes it possible to determine whether the patient belongs to a low-, medium-, or high-risk group of atherosclerosis.
Similar content being viewed by others
References
Elson, J.L., Andrews, R.M., Chinnery, P.F., et al., Analysis of European mtDNA for recombination, Am. J. Hum. Genet., 2001, vol. 68, no. 1, pp. 145–153.
Wallace, D.C., Brown, M.D., and Lott, M.T., Mitochondrial DNA variation in human evolution and disease, Gene, 1999, vol. 238, pp. 211–230.
Sukernik, R.I., Derbeneva, O.A., Starikovskaya, E.B., et al., The mitochondrial genome and human mitochondrial diseases, Russ. J. Genet., 2002, vol. 38, no. 2, pp. 105–113.
Ingman, M., Kaessmann, H., Paabo, S., and Gyllensten, U., Mitochondrial genome variation and the origin of modern humans, Nature, 2000, vol. 408, pp. 708–713. doi 10.1038/35047064
Lightowlers, R.N., Chinnery, P.F., Turnbull, D.M., and Howell, N., Mammalian mitochondrial genetics: heredity, heteroplasmy and disease, Trends. Genet., 1997, vol. 13, no. 11, pp. 450–455.
Robinson, B.H., Human Complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect, Biochem. Biophys. Acta, 1998, vol. 1364, no. 2, pp. 271–286.
Temchenko, A.V., Nikiforov, N.G., Orekhova, V.A., et al., Advances in anti-atherosclerotic therapy, Patogenez, 2013, vol. 11, no. 3, pp. 13–21.
Larsson, N.G. and Clayton, D.F., Molecular genetic aspects of human mitochondrial disorders, Annu. Rev. Genet., 1995, vol. 29, pp. 151–178. doi 10.1146/annurev.ge.29.120195.001055
Sazonova, M.A., Budnikov, E.Yu., Khasanova, Z.B., et al., Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome, Atherosclerosis, 2009, vol. 204, pp. 184–190.
Titov, V.N., Statin-induced inhibition of cholesterol synthesis in liver and very low density lipoproteins: statins, fatty acids and insulin resistance, Pathogenesis, 2013, vol. 11, no. 1, pp. 18–126.
Dalgatov, G.D., Saburina, I.N., Zurina, I.M., et al., Pathogenetic mechanisms of changes in activity of inflammation and fibrogenesis in patients with chronic diffuse liver disease after combined use of perfluorocarbon emulsions and multipotent mesenchymal stromal cells, Pathogenesis, 2013, vol. 11, no. 1, pp. 65–69.
Chernova, E.V., Sobenin, I.A., Melnichenko, A.A., et al., Serum atherogenicity as a pathogenetic target for direct anti-atherosclerotic therapy, Pathogenesis, 2013, vol. 11, no. 2, pp. 28–41.
Sazonova, M.A., Ivanova, M.M., Zhelankin, A.V., et al., Direct quantification of the mutant allele of the mitochondrial genome, Fundamental. Nauki Prakt., 2010, vol. 1, no. 2, pp. 19–21.
Mitrofanov, K.Yu. and Sazonova, M.A., Association of point mutations of nuclear and mitochondrial genomes of a person with coronary heart disease, Patol. Fiziol. Eksp. Ter., 2012, no. 2, pp. 51–56.
Sazonova, M.A., Sinev, V.V., Chicheva, M.M., et al., Association of heteroplasmic mutations of mitochondrial RNA genes with homogenates of atherosclerosisaffected aorta intima, Patol. Fiziol. Eksp. Ter., 2012, no. 4, pp. 67–70.
Ivanova, M.M., Borodachev, E.N., and Sazonova, M.A., Human diseases associated with mitochondrial genome mutations, Patol. Fiziol. Eksp. Ter., 2012, no. 3, pp. 115–122.
Bobryshev, Yu.V. and Orekhov, A.N., Dendritic cells in atherogenesis: identification and pathophysiological significance, Patogenez, 2013, vol. 11, no. 1, pp. 6–15.
Bukrinskii, M.I., Karagodin, V.P., Orekhova, V.A., et al., Dependence of cholesterol metabolism on Nef expression in HIV-infected cells, Patogenez, 2011, vol. 9, no. 1, pp. 34–37.
Sambrook, J. and Russell, D.W., Commonly used techniques in molecular cloning, in Molecular Cloning, New York: Cold Spring Harbor Laboratory Press, 2001, vol. 3, appendix 8, 3rd ed.
Savostina, E.P. and Arsent’eva, L.A., Methodical approaches in the forensic molecular genetic examinations, Probl. Ekspert. Med., 2011, vol. 11, no. 3, pp. 22–26.
Primer3 (v. 0.4.0). Pick primers from a DNA sequence. http://frodo.wi.mit.edu/.Accessed September 22, 2012.
Oligo Calc: Oligonucleotide Properties Calculator. http://www.basic.northwestern.edu/biotools/Oligo-Calc.html. Accessed August 10, 2012.
The UNAFold Web Server. http://mfold.rna.albany.edu/?q=dinamelt. Accessed October 5, 2012.
Primer-BLAST. http://www.ncbi.nlm.nih.gov/tools/primer-blast/.Accessed September 22, 2012.
BLAST (Basic Local Alignment Search Tool). http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn& BLAST_PROGRAMS=megaBlast&PAGE_TYPE= BlastSearch. Accessed September 22, 2012.
Homo sapiens mitochondrion, complete genome. NCBI Reference Sequence: NC_012920.1. http://www.ncbi.nlm.nih.gov/nuccore/NC_012920. Accessed September 22, 2012.
Lang, T.A. and Secic, M., How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors, and Reviewers, Philadelphia: American College of Physicians, 2006, 2nd ed.
Wang, L., Chen, Z.-J., Zhang, Y.-K., and Le, H.-B., The role of mitochondrial tRNA mutations in lung cancer, Int. J. Clin. Exp. Med., 2015, vol. 8, no. 8, pp. 13341–13346.
Krupnova, E.V., Shapetska, M.N., Mikhalenko, E.P., et al., Role of vascular endothelial growth factor in nonsmall cell lung cancer pathogenesis, Exp. Oncol., 2015, vol. 37, no. 3, pp. 213–217.
Sun, Q., Arnold, R.S., Sun, C.Q., and Petros, J.A., A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer, Prostate, 2015, vol. 75, no. 16, pp. 1916–1925.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © K.Y. Mitrofanov, V.P. Karagodin, Z.B. Khasanova, N.A. Orekhova, A.N. Orekhov, I.A. Sobenin, 2018, published in Genetika, 2018, Vol. 54, No. 1, pp. 122–130.
Rights and permissions
About this article
Cite this article
Mitrofanov, K.Y., Karagodin, V.P., Khasanova, Z.B. et al. A Method for Measuring the Heteroplasmy Level of Mitochondrial DNA Mutations. Russ J Genet 54, 121–128 (2018). https://doi.org/10.1134/S1022795417100064
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795417100064